Login    Join free Add to favorites    中文
home > news > 9th World Congress on Bioavailability and Bioequivalence
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
9th World Congress on Bioavailability and Bioequivalence

hits:824     Date:12/12/17

9th World Congress on Bioavailability and Bioequivalence

April 16-18, 2018 鈭 Dubai ,UAE
Theme: Unfolding Innovations in Bioequivalence and Bioavailability and Related Science
Conference short name: BABE 2018
We are so glad to organize 鈥9th World Congress on Bioavailability and Bioequivalence鈥 (BABE 2018) in UAE on April 16-18, 2018 at Dubai after a similar series of conferences in consecutive years at USA over the last several years which met with great achievement in Business Conferencing. This unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modelling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving bioavailability bioequivalence research. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.
BABE 2018 is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF (student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Target audience:
  • CEOs, CROs, Directors, Managers and research associates
  • Academic and Industrial Scientists
  • Regulatory and Clinical Scientists
  • Researchers, Education providers
  • Students and Postdoctoral Fellows
  • Government Agencies
  • Medical Practitioners
  • Clinical Pharmacologists
  • Clinical Toxicologists
  • Molecular and Cellular Pharmacologists
Conference Highlights
Bioavailability and Bioequivalence
Bioavailability Studies and Assessment
Bioequivalence Studies and Assessment
Drug Design and development: Challenges
Drug Metabolism
Pharmacology- PK & PD approach
Pharmaceutical Formulations
Clinical Research Vs Clinical Trails
BCS & IVIVC Based Biowaivers
Biosimilars: Recent approaches
Drug Safety: Pharmacovigilance Scope
Contract Research Organizations
Regulatory Requirements and Approaches
Pharmaceutical Industry: Entrepreneur Meet
BA/BE Perspectives for Drug Products
contact :
Patrica Jones
Program Manager
BABE 2018
Kemp House,
152 City Road,
London EC1V 2NX,
Direct:(702) 508-5200 Ext:8122
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙